DOPAMINE METABOLISM IN THE CENTRAL NERVOUS-SYSTEM AFTER DISCONTINUATION OF L-DOPA THERAPY IN PATIENTS WITH PARKINSON DISEASE

被引：49
|
作者：
OGASAHARA, S
NISHIKAWA, Y
TAKAHASHI, M
WADA, K
NAKAMURA, Y
YORIFUJI, S
TARUI, S
机构：
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 1984年 / 66卷 / 2-3期
关键词：
D O I：
10.1016/0022-510X(84)90003-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：151 / 163
页数：13
相关论文
共 50 条
  • [41] L-dopa, dopamine and noradrenaline metabolism in Catechol-O-Methyltransferase (COMT)-disrupted mice in normal condition and after L-dopa injection
    Huotari, M
    Gogos, JA
    Karayiorgou, ML
    Hyttinen, J
    Männistö, PT
    MONITORING MOLECULES IN NEUROSCIENCE, 2001, : 215 - 216
  • [42] L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
    Peter Riederer
    Reinhard Horowski
    Journal of Neural Transmission, 2023, 130 : 1323 - 1335
  • [43] Effect of dopamine depletion and L-dopa therapy on glutamatergic synapses on striatopallidal neurons in macaque model of Parkinson's disease
    Guigoni, C.
    Doudnikoff, E.
    Li, Q.
    Bloch, B.
    Bezard, E.
    MOVEMENT DISORDERS, 2006, 21 : S347 - S347
  • [44] THE ROLE OF L-DOPA IN THE NERVOUS-SYSTEM OF SEA-ANEMONES - A PUTATIVE INHIBITORY TRANSMITTER IN TENTACLES
    HUDMAN, D
    MCFARLANE, ID
    JOURNAL OF EXPERIMENTAL BIOLOGY, 1995, 198 (04): : 1045 - 1050
  • [45] L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease
    Isobe, Chiaki
    Abe, Takashi
    Terayama, Yasuo
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (06) : 717 - 721
  • [46] L-dopa therapy increases the homocysteine concentrations in the cerebrospinal fluid from patients with Parkinson's disease
    Isobe, C.
    Abe, T.
    Murata, T.
    Ohtsuka, C.
    Hattori, N.
    Terayama, Y.
    MOVEMENT DISORDERS, 2009, 24 : S222 - S222
  • [47] The dopamine agonist Piribedil with L-DOPA improves attentional dysfunction: Relevance for Parkinson's disease
    Turle-Lorenzo, Nathalie
    Maurin, Beatrice
    Puma, Carole
    Chezaubernard, Claire
    Morain, Philippe
    Baunez, Christelle
    Nieoullon, Andre
    Amalric, Marianne
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02): : 914 - 923
  • [48] Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease
    Li, J
    Zhu, M
    Manning-Bog, AB
    Di Monte, DA
    Fink, AL
    FASEB JOURNAL, 2004, 18 (06): : 962 - +
  • [49] EXCRETION OF DOPA METABOLITES IN PATIENTS WITH PARKINSONS DISEASE WHO ARE RECEIVING L-DOPA THERAPY
    ROUTH, JI
    CLINICAL CHEMISTRY, 1970, 16 (06) : 535 - &
  • [50] Early Addition of Selegiline to L-Dopa Treatment is Beneficial for Patients With Parkinson Disease
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Kuno, Sadako
    Nomoto, Masahiro
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (01) : 1 - 4
12345